Spain Wary Over Biogenerics

To read the full article, please choose one of the following options:

Spain's Ministry of Health (MoH) is reportedly hesitant to promote biosimilars - generic copies of biotechnology drugs - due to concerns that they do not have bioequivalency to the originator products.